Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial

Autor: Mary Kathryn Dahlgren, Ashley M. Lambros, Rosemary T. Smith, Kelly A. Sagar, Celine El-Abboud, Staci A. Gruber
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Communications Medicine, Vol 2, Iss 1, Pp 1-10 (2022)
Druh dokumentu: article
ISSN: 2730-664X
DOI: 10.1038/s43856-022-00202-8
Popis: Dahlgren et al. conduct an open-label phase 2 trial of a full-spectrum, high-cannabidiol product in 14 patients with moderate-to-severe anxiety. Anxiety is significantly reduced and the drug well-tolerated with no serious adverse events.
Databáze: Directory of Open Access Journals
Externí odkaz: